Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cross Country Healthcare (CCRN) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to 2.39%.

  • Cross Country Healthcare's EBIT Margin fell 32900.0% to 2.39% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.44%, marking a year-over-year decrease of 14400.0%. This contributed to the annual value of 1.25% for FY2024, which is 68400.0% down from last year.
  • Latest data reveals that Cross Country Healthcare reported EBIT Margin of 2.39% as of Q3 2025, which was down 32900.0% from 2.14% recorded in Q2 2025.
  • Cross Country Healthcare's 5-year EBIT Margin high stood at 11.86% for Q4 2021, and its period low was 5.65% during Q2 2024.
  • In the last 5 years, Cross Country Healthcare's EBIT Margin had a median value of 4.79% in 2021 and averaged 4.18%.
  • As far as peak fluctuations go, Cross Country Healthcare's EBIT Margin skyrocketed by 111100bps in 2021, and later tumbled by -121600bps in 2024.
  • Over the past 5 years, Cross Country Healthcare's EBIT Margin (Quarter) stood at 11.86% in 2021, then tumbled by -35bps to 7.68% in 2022, then tumbled by -58bps to 3.24% in 2023, then crashed by -134bps to 1.11% in 2024, then crashed by -116bps to 2.39% in 2025.
  • Its last three reported values are 2.39% in Q3 2025, 2.14% for Q2 2025, and 0.33% during Q1 2025.